Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05896696 · ClinicalTrials.gov registry record · NA
Efficacy and Safety of the BeShape One Device for Non-invasive Waist Circumference Reduction
A NA study of Dermatological Non-Disease, sponsored by BeShape Technologies.
- Completed
- Registry status
- NA
- Development phase
- 81
- Enrollment target
- 2
- Study locations
NCT05896696 is a NA study of Dermatological Non-Disease that has completed, run by BeShape Technologies. The registered enrollment target is 81 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT05896696, a NA study of Dermatological Non-Disease, has completed, sponsored by BeShape Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 81 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this clinical trial is to evaluate the safety and efficacy of the BeShape One device for non-invasive waist circumference reduction in adults between the ages of 18 and 65. The main question\[s\] it aims to answer are: * reduction in waist circumference following treatment with the BeShape One device at the final 6 and 12-week follow-up visits compared to baseline * Subject improvement and satisfaction * Investigator satisfaction * Subject comfort/pain level Participants will undergo a single treatment with the BeShape One device at the Baseline visit and will return for two follow up visits at 6 and 12 weeks post treatment. Researchers will compare the results at the follow up visits to Baseline.
Conditions Studied
Interventions
- DEVICE BeShape One
Study Locations (2)
Illinois
- Chicago Cosmetic Surgery and Dermatology - Chicago
Other
- Centro Poliklinika - Vilnius
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2022-04-28 |
| Est. Completion | 2023-04-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05896696
The ClinicalTrials.gov registry entry for NCT05896696 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BeShape Technologies, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Dermatological Non-Disease appearing as the primary indexed condition, and to 1 intervention - of which BeShape One is the first listed.
NCT05896696 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Illinois, Other.
Frequently Asked Questions
What is clinical trial NCT05896696 about?
NCT05896696 is a clinical study titled "Efficacy and Safety of the BeShape One Device for Non-invasive Waist Circumference Reduction". The goal of this clinical trial is to evaluate the safety and efficacy of the BeShape One device for non-invasive waist circumference reduction in adults between the ages of 18 and 65. The main question\[s\] it aims to answer are: * reduction in waist circumference following treatment with the BeSh...
What is the current status of trial NCT05896696?
This trial is currently completed. It is a NA study. The enrollment target is 81 participants. The study started on 2022-04-28. Estimated completion is 2023-04-27.
What conditions does trial NCT05896696 study?
This clinical trial studies the following conditions: Dermatological Non-Disease.
What interventions are being tested in trial NCT05896696?
The interventions under investigation include: BeShape One (DEVICE).
Who is sponsoring clinical trial NCT05896696?
This trial is sponsored by BeShape Technologies, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05896696 being conducted?
This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dermatological Non-Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.